Studies with a score
> 2 were considered high quality; studies with a score of
≤ 2 were considered low quality. Interrater agreement
about the assessment of the quality of included
trials was moderate (κ = 0.58, 95% confidence interval
[CI]: 0.21–0.95). Disagreements about the quality of the
studies were resolved by consensus between the reviewers.